AlphAIAlphAI — Financial news for AI agents
finanznachrichten.de

Alithya Group Inc.: Alithya Reports First Quarter Fiscal 2027 Results

Alithya Group Inc. (TSX: ALYA) reported Q1 fiscal 2027 results for the quarter ended June 30, 2026. Revenues fell 15.4% to C$105.1m and gross margin to C$31.9m. Net loss was C$2.4m (loss of C$0.03/share) versus net earnings last year. Adjusted EBITDA dropped to C$5.4m. The board launched a strategic review with Scotiabank.

Original reporting
finanznachrichten.de
Published Aug 13, 2026, 11:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 11:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$ALYAF
Relevance
8/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

Med
01

Why it matters

The quarter shows revenue decline, margin compression, and a net loss versus prior-year profit, while bookings weakened (book-to-bill 0.85). Combined with the strategic review, this can drive both fundamental de-rating and M&A optionality.

02

Market read

Traders get a fresh earnings datapoint (loss, margin and bookings deterioration) plus a time-sensitive corporate catalyst (strategic review framework) that can change valuation and positioning.

03

What to watch

Backlog is described as about 14 months of trailing revenue, and the company cites healthy client demand despite longer decision and conversion cycles, which could support stabilization if bookings improve.

Relevance 8/10Novelty 7/10Timing: today’s Q1 FY2027 earnings release and strategic review update

Background

Alithya initiated a strategic review process on July 27, 2026 and engaged Scotiabank as financial advisor; this release reports Q1 FY2027 ended June 30, 2026.

Market effects

Sector

Signals continued margin pressure in IT services/consulting and slower client conversion cycles, which can pressure peer sentiment.

Regional

Canadian small/mid-cap tech services names may see correlated risk repricing around strategic review and margin trends.

Global

Limited direct global spillover, but reinforces broader enterprise IT spending caution and M&A/privatization interest in underperforming service firms.

Counterpoint

What could challenge this read

The strategic review could unlock value via sale or recapitalization, so the weak quarter may be a temporary trough rather than a structural decline.

Key entities

  • company
    Alithya Group inc.

    Reported Q1 FY2027 results and disclosed a board-led strategic review exploring alternatives including merger, privatization, or sale.

  • financial_advisor
    Scotiabank

    Engaged as financial advisor to support the strategic review process.

  • executive
    Paul Raymond

    CEO who commented on weaker-than-expected results, longer conversion cycles, and ongoing client demand.

Read at source← All news

Related articles

$ALYAFMed

Alithya Group inc (ALYAF): Financial results for Q2 2027

Alithya Group inc (ALYAF) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Alithya reports second quarter Fiscal 2027 results Bookings (1) reach $108.2 million, with a Book-to-Bill Ratio (1) of 1.05 Q2-2027 Highlights • Revenues of $103.4 million, down 16.8% year-over-year. 82.6% of revenues were generated from clients which we had in the s

SEC EDGAR 6-K
Med

Alithya Group inc (ALYAF): Financial results for Q1 2027

Alithya Group inc (ALYAF) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Alithya reports first quarter Fiscal 2027 results Alithya retains Scotiabank as financial advisor in connection with strategic review process Q1-2027 Highlights • Revenues decreased 15.4% to $105.1 million, compared to $124.2 million for the same quarter last year. 7

SEC EDGAR 6-K
$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

finance.yahoo.com
$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

finance.yahoo.com
$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

finance.yahoo.com
$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.

finance.yahoo.com